Skip to main content
CJC-1295 Research

aidsmap 2006 — CJC-1295 Phase 2 Death Report

Summary

Documents the July 2006 halt of NCT00267527; male participant died ~2-3 hours after 11th weekly injection

Study Details
Study Design

News report of regulatory event

Indication

HIV-associated visceral obesity/lipodystrophy

Risk of Bias Assessment

Contemporaneous reporting; based on ConjuChem press release

Tags
SourceNewsRegulatory DisclosureCjc 1295With DACPhase 2 DeathSafety Event
Metrics
Citations
0
Evidence QualityN/A
Related PeptideCJC-12956 papers